Douglas A. Treco - 06 Aug 2025 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Reporting relationship: Director
Issuer ticker: CRSP
Reported as of: 06 Aug 2025
Net transaction value: +$1,140,600
SEC form: 4
Accepted by SEC: 08 Aug 2025, 16:06:28 UTC
Prior SEC filing: 03 Jul 2025
Next SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Ryland Waldinger, attorney-in-fact

Key filing fact

Douglas A. Treco filed Form 4 for CRISPR Therapeutics AG (CRSP) on 08 Aug 2025.

Key facts

This page summarizes Douglas A. Treco's Form 4 filing for CRISPR Therapeutics AG (CRSP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Aug 2025, 16:06.

Change

Previous filing in this sequence was filed on 03 Jul 2025.
Current net transaction value: +$1,140,600.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001688192 Primary reporting owner

Treco Douglas A

Relationship: Director
Address: C/O CRISPR THERAPEUTICS, 105 WEST FIRST STREET, BOSTON
Signature: /s/ Elizabeth Ryland Waldinger, attorney-in-fact
Signature date: 08 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRSP transaction

Common Shares

Purchase

Transaction value: $1,140,600
Shares: +20,000
Change %: +1000%
Price: $57.03
Shares after: 22,000
Date: 06 Aug 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Open market purchase of shares in accordance with Issuer's trading policies.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.92 to $57.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.